SEC Form 4 · accession 0001209191-17-053822
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
CELGENE CORP
10% Owner
Period of report
Sep 25, 2017
Accepted (ET)
Sep 25, 2017 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 25, 2017 | P | 745,592 | $37.00 | A | 6,118,479 | D |
Table II — derivative securities
No Table II lines on this filing.